Pre-treatment levels of ctDNA may be useful in future clinical trials to predict long-term survival
Pre-treatment circulating tumor (ct)DNA levels more accurately predicted long-term survival than classical survival surrogates in the NADIM study and might be useful for the design of new clinical trials, according to research ...
Sep 13, 2021
0
2